183 related articles for article (PubMed ID: 34153844)
21. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease.
Ren R; Shi C; Cao J; Sun Y; Zhao X; Guo Y; Wang C; Lei H; Jiang H; Ablat N; Xu J; Li W; Ma Y; Qi X; Ye M; Pu X; Han H
Sci Rep; 2016 Feb; 6():22135. PubMed ID: 26906725
[TBL] [Abstract][Full Text] [Related]
23. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
[TBL] [Abstract][Full Text] [Related]
24. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
25. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
[TBL] [Abstract][Full Text] [Related]
26. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
27. Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease.
Van Kampen JM; Baranowski DB; Shaw CA; Kay DG
Exp Gerontol; 2014 Feb; 50():95-105. PubMed ID: 24316034
[TBL] [Abstract][Full Text] [Related]
28. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
29. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
30. Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota.
Malaiwong N; Chalorak P; Jattujan P; Manohong P; Niamnont N; Suphamungmee W; Sobhon P; Meemon K
Biomed Pharmacother; 2019 Jan; 109():1967-1977. PubMed ID: 30551452
[TBL] [Abstract][Full Text] [Related]
31. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
32. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
[TBL] [Abstract][Full Text] [Related]
33. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
[No Abstract] [Full Text] [Related]
35. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
Xu L; Liu LX; Chen WF; Xie JX; Huang WX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
[TBL] [Abstract][Full Text] [Related]
36. Plastrum Testudinis Extracts Promote NSC Differentiation into Dopaminergic Neuron by Regulating the Interaction of TET1 and FoxA2.
Zhong J; Ye S; Zhou X; Huang J; Li X; Zhang S; Zhou J; Chen D; Li C
Evid Based Complement Alternat Med; 2020; 2020():9104135. PubMed ID: 32382312
[TBL] [Abstract][Full Text] [Related]
37. Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
Goulding SR; Sullivan AM; O'Keeffe GW; Collins LM
Parkinsonism Relat Disord; 2019 Jul; 64():194-201. PubMed ID: 31000327
[TBL] [Abstract][Full Text] [Related]
38. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.
Du XX; Xu HM; Jiang H; Song N; Wang J; Xie JX
Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825
[TBL] [Abstract][Full Text] [Related]
39. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
40. Central neuropeptide-S treatment improves neurofunctions of 6-OHDA-induced Parkinsonian rats.
Bülbül M; Sinen O; Özkan A; Aslan MA; Ağar A
Exp Neurol; 2019 Jul; 317():78-86. PubMed ID: 30825442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
